Literature DB >> 21094643

The retroviral proteinase active site and the N-terminus of Ddi1 are required for repression of protein secretion.

Rhian E White1, J Richard Dickinson, Colin A M Semple, David J Powell, Colin Berry.   

Abstract

The Ddi1 protein of the yeast Saccharomyces cerevisiae is involved in numerous interactions with the ubiquitin system, which may be mediated by its N-terminal ubiquitin like domain and its C-terminal ubiquitin associated domain. Ddi1 also contains a central region with all the features of a retroviral aspartic proteinase, which was shown to be important in cell-cycle control. Here we demonstrate an additional role for this domain, along with the N-terminal region, in protein secretion. These results further substantiate the hypothesis that Ddi1 functions in vivo as a catalytically-active aspartic proteinase.
Copyright © 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094643     DOI: 10.1016/j.febslet.2010.11.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Two duplicated genes DDI2 and DDI3 in budding yeast encode a cyanamide hydratase and are induced by cyanamide.

Authors:  Jia Li; Michael Biss; Yu Fu; Xin Xu; Stanley A Moore; Wei Xiao
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

Review 2.  The ubiquitin-proteasome system of Saccharomyces cerevisiae.

Authors:  Daniel Finley; Helle D Ulrich; Thomas Sommer; Peter Kaiser
Journal:  Genetics       Date:  2012-10       Impact factor: 4.562

3.  Ddi1-like protein from Leishmania major is an active aspartyl proteinase.

Authors:  María J Perteguer; Paulino Gómez-Puertas; Carmen Cañavate; Francehuli Dagger; Teresa Gárate; Elizabeth Valdivieso
Journal:  Cell Stress Chaperones       Date:  2012-08-30       Impact factor: 3.667

4.  Protein Composition of Infectious Spores Reveals Novel Sexual Development and Germination Factors in Cryptococcus.

Authors:  Mingwei Huang; Alexander S Hebert; Joshua J Coon; Christina M Hull
Journal:  PLoS Genet       Date:  2015-08-27       Impact factor: 5.917

5.  HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites.

Authors:  Rhian E White; David J Powell; Colin Berry
Journal:  FASEB J       Date:  2011-01-25       Impact factor: 5.191

6.  Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1.

Authors:  Nicolas J Lehrbach; Gary Ruvkun
Journal:  Elife       Date:  2016-08-16       Impact factor: 8.140

7.  Structural studies of the yeast DNA damage-inducible protein Ddi1 reveal domain architecture of this eukaryotic protein family.

Authors:  Jean-François Trempe; Klára Grantz Šašková; Monika Sivá; Colin D H Ratcliffe; Václav Veverka; Annabelle Hoegl; Marie Ménade; Xin Feng; Solomon Shenker; Michal Svoboda; Milan Kožíšek; Jan Konvalinka; Kalle Gehring
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

8.  ERG-28 controls BK channel trafficking in the ER to regulate synaptic function and alcohol response in C. elegans.

Authors:  Kelly H Oh; James J Haney; Xiaohong Wang; Chiou-Fen Chuang; Janet E Richmond; Hongkyun Kim
Journal:  Elife       Date:  2017-02-07       Impact factor: 8.140

9.  DDI2 Is a Ubiquitin-Directed Endoprotease Responsible for Cleavage of Transcription Factor NRF1.

Authors:  A Barbara Dirac-Svejstrup; Jane Walker; Peter Faull; Vesela Encheva; Vyacheslav Akimov; Michele Puglia; David Perkins; Sandra Kümper; Suchete S Hunjan; Blagoy Blagoev; Ambrosius P Snijders; David J Powell; Jesper Q Svejstrup
Journal:  Mol Cell       Date:  2020-06-09       Impact factor: 17.970

10.  Human DNA-Damage-Inducible 2 Protein Is Structurally and Functionally Distinct from Its Yeast Ortholog.

Authors:  Monika Sivá; Michal Svoboda; Václav Veverka; Jean-François Trempe; Kay Hofmann; Milan Kožíšek; Rozálie Hexnerová; František Sedlák; Jan Belza; Jiří Brynda; Pavel Šácha; Martin Hubálek; Jana Starková; Iva Flaisigová; Jan Konvalinka; Klára Grantz Šašková
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.